Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction

Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction

Background/Aim. Up-to-date treatment of acute myocardial infarction (AIM) has been based on as early as possible establishment of circulation in ischemic myocardium whether by the use of fibrinolythic therapy and/or urgent coronary intervention which significantly changes the destiny of patients wit...

Full description

Bibliographic Details
Main Authors:	Kostić Tomislav, Perišić Zoran, Milić Dragan, Apostolović Svetlana, Šalinger-Martinović Sonja, Božinović Nenad, Mitov Vladimir, Vidanović Miroslav
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2009-01-01
Series:	Vojnosanitetski Pregled
Subjects:	acute coronary syndrome myocardial infarction streptokinase tissue plazminogen activator hemorrhage treatment outcome
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2009/0042-84500903218K.pdf

Similar Items

Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction
by: Tomašević Miloje, et al.
Published: (2008-01-01)

Re‐establishing indwelling pleural catheter patency with alteplase after failure of streptokinase
by: Mohamed Faisal, et al.
Published: (2020-10-01)

PLASMINOGEN ACTIVATION BY LOW MOLECULAR WEIGHT STREPTOKINASE AND FIBRIN EFFECT
by: E. I. Yusova
Published: (2014-06-01)

Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction
by: V. A. Stolyarov, et al.
Published: (2005-04-01)

Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
by: Himmatrao S Bawaskar, et al.
Published: (2019-01-01)

Fibrinolytic Activity of Recombinant Mutant Streptokinase
by: Mahboobeh Mobarrez, et al.
Published: (2015-04-01)

The Comparison between the Outcomes of Streptokinase and Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
Published: (2017-07-01)

Comparing Two Nomograms of Heparin Dosing after Receiving Streptokinase
by: M Modares Mosadegh, et al.
Published: (2015-10-01)

Expression of Recombinant Streptokinase from Streptococcus Pyogenes and Its Reaction with Infected Human and Murine Sera
by: Neda Molaee, et al.
Published: (2013-09-01)

Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase
by: Hossein Saidi, et al.
Published: (2013-12-01)

Fermentation, fractionation and purification of streptokinase by chemical reduction method
by: Z Karimi, et al.
Published: (2011-03-01)

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen
by: Ahmed Bendary, et al.
Published: (2017-12-01)

Intrapleural Streptokinase in Management of Multiloculated Uraemic Pleural Effusion- A case report
by: Rawat J, et al.
Published: (2006-01-01)

The Study of Interval between Onset of the Clinical Symptoms and Streptokinase Receiving in Patients with Acute Myocardial Infarction
by: Adalat Hoseinian, et al.
Published: (2012-04-01)

A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients
by: Md. Anup Rahman Chowdhury, et al.
Published: (2008-04-01)

A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients
by: Nur-A-Farhana Islam, et al.
Published: (2008-06-01)

Massive hemothorax following administration of intrapleural streptokinase
by: Chai Feng, et al.
Published: (2011-01-01)

Using streptokinase for pleural adhesiolysis in sonographically septated pleural effusion
by: Amany Omar, et al.
Published: (2015-10-01)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
by: Mojtaba Salarifar, et al.
Published: (2009-01-01)

Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
by: Navid Paydari, et al.
Published: (2009-03-01)

Treatment of femoral artery thrombosis with streptokinase and heparin after cardiac catheterization
by: Hojjat Mortezaiyan, et al.
Published: (2014-01-01)

Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic /Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
by: Maryam Rafipour, et al.
Published: (2020-01-01)

STREPTOKINASE EFFICACY IN MYOCARDIAL INFARCTION MANAGEMENT: IS IT RELATED TO SERUM ANTISTREPTOKINASE ANTIBODY TITER
by: H SHEMIRANI, et al.
Published: (2000-06-01)

The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction
by: Ya. L. Gabinsky, et al.
Published: (2006-12-01)

Spontaneous psoas hematoma in a case of acute myocardial infarction following streptokinase infusion
by: B. Sunil Abhishek, et al.
Published: (2016-09-01)

Streptokinase Adverse Reactions: A Review of Iranian Literature
by: Ava Mansouri, et al.
Published: (2015-10-01)

Is accelerated idioventricular rhythm a good marker for reperfusion after streptokinase?
by: Ashar Khan, et al.
Published: (2016-05-01)

Site-Directed Mutation, Cloning and Expression of Streptokinase for Producing a New Suitable Molecule for PEGylation
by: Somayeh Bagheri, et al.
Published: (2016-06-01)

Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent
by: I. Daruwati, et al.
Published: (2012-12-01)

An Uncommon Complication of Streptokinase: Large Spontaneous Iliopsoas Hematoma
by: Raheleh Aliabadi, et al.
Published: (2017-08-01)

Cloning and expression of truncated and intact streptokinase molecules in E.coli and evaluation of their biological activities
by: Reza Arabi, et al.
Published: (2010-05-01)

Cloning, expression and purification of recombinant streptokinase: partial characterization of the protein expressed in Escherichia coli
by: L. Avilán, et al.
Published: (1997-12-01)

Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay
by: Couto L.T., et al.
Published: (2004-01-01)

The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
by: Deep Chandh Raja, et al.
Published: (2017-09-01)

Comparison of Streptokinase Activity from Streptococcus mutans using Different Substrates
by: Muhammad Anjum Zia*, Rana Faisal, Rao Zahid Abbas1, Gull-e-Faran, Muhammad Kashif Saleemi2 and Junaid Ali Khan3
Published: (2013-01-01)

Enhanced Production Of Streptokinase By Chemical Mutagenesis Of Streptococcus agalactiae EBL-20
by: Arooj Arshad, et al.
Published: (2019-05-01)

Dysrhythmias Induced by Streptokinase Infusion in Patients with Acute Myocardial Infarction Admitted to Cardiac Care Units in the Northwest of Iran
by: Parizad Razieh, et al.
Published: (2014-01-01)

Efficacy and safety of high dose versus low dose streptokinase for treatment of submassive pulmonary embolism
by: Ayman A. Abdelsamad, et al.
Published: (2011-06-01)

Streptokinase in the Treatment of Venous Sinus Thrombosis: A Case Report
by: Yuan-Han Yang, et al.
Published: (2003-08-01)

Initial evidence of safety and clinical effect of recombinant streptokinase suppository in acute hemorrhoidal disease. Open, proof-of-concept, pilot trial
by: Liván Quintero, et al.